- Home
- SGMT vs REE Comparison
SGMT vs REE Comparison
Compare SGMT & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- REE
- Stock Information
- Founded
- SGMT 2006
- REE 2011
- Country
- SGMT United States
- REE Israel
- Employees
- SGMT N/A
- REE N/A
- Industry
- SGMT
- REE Auto Manufacturing
- Sector
- SGMT
- REE Consumer Discretionary
- Exchange
- SGMT Nasdaq
- REE Nasdaq
- Market Cap
- SGMT 128.5M
- REE 115.5M
- IPO Year
- SGMT 2023
- REE N/A
- Fundamental
- Price
- SGMT $3.72
- REE $2.75
- Analyst Decision
- SGMT Strong Buy
- REE Strong Buy
- Analyst Count
- SGMT 6
- REE 2
- Target Price
- SGMT $25.67
- REE $14.50
- AVG Volume (30 Days)
- SGMT 315.0K
- REE 180.2K
- Earning Date
- SGMT 03-12-2025
- REE 04-29-2025
- Dividend Yield
- SGMT N/A
- REE N/A
- EPS Growth
- SGMT N/A
- REE N/A
- EPS
- SGMT N/A
- REE N/A
- Revenue
- SGMT N/A
- REE $626,000.00
- Revenue This Year
- SGMT N/A
- REE N/A
- Revenue Next Year
- SGMT N/A
- REE $21,460.67
- P/E Ratio
- SGMT N/A
- REE N/A
- Revenue Growth
- SGMT N/A
- REE N/A
- 52 Week Low
- SGMT $2.39
- REE $2.66
- 52 Week High
- SGMT $7.38
- REE $11.72
- Technical
- Relative Strength Index (RSI)
- SGMT 44.81
- REE 19.63
- Support Level
- SGMT $3.70
- REE $5.66
- Resistance Level
- SGMT $4.24
- REE $4.01
- Average True Range (ATR)
- SGMT 0.23
- REE 0.62
- MACD
- SGMT 0.04
- REE -0.16
- Stochastic Oscillator
- SGMT 45.70
- REE 2.28
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.